Phosphomevalonate kinase (PMVK) is a critical enzyme in the mevalonate pathway, and recent work shows it drives tumor progression via metabolite-dependent activation of Wnt/β-catenin signaling [Chen et al., 2023]. Here, PMVK is linked to neoplasm.